Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated just now
Peer-reviewedCC BY-NC 4.0Diabetes, Metabolic Syndrome and Obesity

Gut Microbiota Signaling Axes as Candidate Therapeutic Targets in Type 2 Diabetes Mellitus: Mechanistic Crosstalk and Translational Challenges

  1. 1College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, Jilin, 130117, People’s Republic of China
  2. 2Department of Acupuncture and Moxibustion, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, 130021, People’s Republic of China

Abstract

Gut microbiota disturbance serves as a critical pathogenic factor for metaflammation (metabolic inflammation) and insulin resistance in type 2 diabetes mellitus (T2DM). Growing preclinical evidence demonstrates that gut microbial metabolites modulate systemic metabolic and immune homeostasis via multiple interactive signaling axes rather than independent single pathways. This narrative review systematically summarizes four core signaling axes derived from gut microbiota. These axes include the SCFAs–AMPK energy-sensing axis, the BA- FXR/TGR5 metabolic regulatory axis, the LPS–TLR4/NF-κB proinflammatory axis, and the tryptophan–AhR intestinal barrier repair axis. This work further discusses the crosstalk among these axes and their potential functional roles in T2DM progression. We propose that intestinal metabolic and immune homeostasis relies on the dynamic balance between protective metabolic pathways and proinflammatory injury pathways. Consistent with cumulative preclinical findings, the NF-κB/NLRP3 inflammasome complex acts as a potential downstream convergence node. This node integrates upstream microbial metabolic disorders, amplifies chronic low-grade inflammatory cascades, and subsequently induces intestinal barrier impairment, insulin resistance and T2DM deterioration.This review further defines two conceptual regulatory patterns of relevant signaling networks. One is the synergistic homeostatic protection dominated by energy-sensing pathways, and the other is the antagonistic pathological imbalance triggered by excessive inflammatory activation. This study also highlights major existing limitations in current research. These limitations involve insufficient investigations into multimodule crosstalk, ambiguous spatiotemporal regulatory characteristics of core inflammatory hubs, and inadequate clinical translational validation. In conclusion, the dysregulation of multiple interactive signaling axes disrupts metabolic and immune homeostasis, which constitutes a preclinically validated upstream pathogenic mechanism for T2DM and requires further comprehensive verification in human clinical cohorts. Conventional therapeutic strategies focus on single-target intervention. The transformation toward precise combinatorial strategies targeting the gut microbiota-associated multi-signal network can provide novel theoretical references and translational directions for early intervention and holistic management of T2DM. Nevertheless, clinical evidence supporting simultaneous multi-axis targeted intervention remains insufficient.

Related

  1. Dynamic three-dimensional chromatin remodeling in lung disease: mechanistic principles, pathogenic regulatory networks, and translational challenges
    Tiantian Liu, Songshan Jiang, Jing Wang +1
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. The Microbiota-Metabolism Axis: Mechanistic Insights and Translational Targets Across Diabetes and Gastrointestinal Disorders.
    Adnan Akif, Nigar Sultana, Ishtyaque Mikrani
    International journal of endocrinologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  3. Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges
    Min Qiao, Chang Sun, Yangyang Qin +5
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  4. Microbiota–host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicine
    Jing Chen, Jing Du, Baoxi Mu +3
    Frontiers in pharmacologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  5. Natural Bitter Compounds, Intestinal TAS2Rs, and GLP-1 Secretion: Mechanistic Evidence and Translational Challenges
    Wenmin Lao, Xiaojing Liu, Jiefang Zhou +4
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
BibTeX
@article{zhang2026microbiota,
  title = {{Gut Microbiota Signaling Axes as Candidate Therapeutic Targets in Type 2 Diabetes Mellitus: Mechanistic Crosstalk and Translational Challenges}},
  author = {Yiyue Zhang and Tong Zhang and Yahong Tian and Haili Wang and Xinhua Chen},
  journal = {Diabetes, Metabolic Syndrome and Obesity},
  year = {2026},
  month = nov,
  doi = {10.2147/dmso.s646274},
  url = {https://doi.org/10.2147/dmso.s646274},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Gut Microbiota Signaling Axes as Candidate Therapeutic Targets in Type 2 Diabetes Mellitus: Mechanistic Crosstalk and Translational Challenges
AU  - Yiyue Zhang
AU  - Tong Zhang
AU  - Yahong Tian
AU  - Haili Wang
AU  - Xinhua Chen
PY  - 2026
DA  - 2026/11/02
JO  - Diabetes, Metabolic Syndrome and Obesity
DO  - 10.2147/dmso.s646274
UR  - https://doi.org/10.2147/dmso.s646274
AB  - Gut microbiota disturbance serves as a critical pathogenic factor for metaflammation (metabolic inflammation) and insulin resistance in type 2 diabetes mellitus (T2DM). Growing preclinical evidence demonstrates that gut microbial metabolites modulate systemic metabolic and immune homeostasis via multiple interactive signaling axes rather than independent single pathways. This narrative review systematically summarizes four core signaling axes derived from gut microbiota. These axes include the SCFAs–AMPK energy-sensing axis, the BA- FXR/TGR5 metabolic regulatory axis, the LPS–TLR4/NF-κB proinflammatory axis, and the tryptophan–AhR intestinal barrier repair axis. This work further discusses the crosstalk among these axes and their potential functional roles in T2DM progression. We propose that intestinal metabolic and immune homeostasis relies on the dynamic balance between protective metabolic pathways and proinflammatory injury pathways. Consistent with cumulative preclinical findings, the NF-κB/NLRP3 inflammasome complex acts as a potential downstream convergence node. This node integrates upstream microbial metabolic disorders, amplifies chronic low-grade inflammatory cascades, and subsequently induces intestinal barrier impairment, insulin resistance and T2DM deterioration.This review further defines two conceptual regulatory patterns of relevant signaling networks. One is the synergistic homeostatic protection dominated by energy-sensing pathways, and the other is the antagonistic pathological imbalance triggered by excessive inflammatory activation. This study also highlights major existing limitations in current research. These limitations involve insufficient investigations into multimodule crosstalk, ambiguous spatiotemporal regulatory characteristics of core inflammatory hubs, and inadequate clinical translational validation. In conclusion, the dysregulation of multiple interactive signaling axes disrupts metabolic and immune homeostasis, which constitutes a preclinically validated upstream pathogenic mechanism for T2DM and requires further comprehensive verification in human clinical cohorts. Conventional therapeutic strategies focus on single-target intervention. The transformation toward precise combinatorial strategies targeting the gut microbiota-associated multi-signal network can provide novel theoretical references and translational directions for early intervention and holistic management of T2DM. Nevertheless, clinical evidence supporting simultaneous multi-axis targeted intervention remains insufficient.
SN  - 1178-7007
ER  -